mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.2 |